M

Marinus Pharmaceuticals
D

MRNS

0.23870
USD
-0.00
(-0.50%)
مغلق
حجم التداول
0
الربح لكل سهم
-2
العائد الربحي
-
P/E
-0
حجم السوق
13,172,808
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    A
    ACAD
    0.140
    (0.84%)
    16.880 USD
    ALNY
    ALNY
    6.675
    (2.79%)
    245.505 USD
    B
    BPMC
    1.130
    (1.27%)
    90.120 USD
    I
    INSM
    1.080
    (1.56%)
    70.440 USD
    K
    KPTI
    0.00170
    (0.26%)
    0.64430 USD
    P
    PTCT
    1.000
    (2.21%)
    46.200 USD
    S
    SAGE
    0.60500
    (12.09%)
    5.61000 USD
    Z
    ZYNE
    0
    (0%)
    0.000000 USD
    المزيد
الأخبار

العنوان: Marinus Pharmaceuticals

القطاع: Healthcare
الصناعة: Biotechnology
Marinus Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is focused on developing and commercializing innovative therapeutics to treat epilepsy and neuropsychiatric disorders. Marinus manages the business in one segment, which is the identification and development of neuropsychiatric therapeutics. The Company is developing ganaxolone for multiple epilepsy and other neuropsychiatric indications, including adjunctive, or add-on, therapy for the treatment of drug-resistant focal onset seizures; status epilepticus; Fragile X Syndrome, and PCDH19-RE.